NCT01774435View on ClinicalTrials.gov

Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Schizophrenia
Interventions
DRUG

EN3342

Trial Locations (1)

Unknown

CRI Lifetree, Marlton

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY